# High-Flow Nasal Oxygen Therapy for Exacerbation of Chronic Pulmonary Obstructive Disease.

> **NCT03488628** · NA · COMPLETED · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 51 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **OTHER:** Noninvasive ventilation
- **OTHER:** High-Flow Nasal Oxygen therapy

## Key facts

- **NCT ID:** NCT03488628
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-27
- **Primary completion:** 2025-10-03
- **Final completion:** 2025-10-30
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03488628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03488628, "High-Flow Nasal Oxygen Therapy for Exacerbation of Chronic Pulmonary Obstructive Disease.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03488628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*